anurajms/meta_analysis huggingface dataset:
outcomes:
Ketogenic diets for drug‐resistant epilepsy
1. Seizure Free 2. Seizure Related Finding 3. Adverse Event
outcomes:
Cognitive‐behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour
1. Criminal Behavior 2. Sexual Offending Behavior 3. Criminal Activity 4. Sexual Aggression
outcomes:
Pitavastatin for lowering lipids
1. Low Density Lipoprotein Cholesterol Measurement
outcomes:
Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children
1. Minor Bleed 2. Thrombosis 3. Major Bleed
outcomes:
Ventriculo‐peritoneal shunting devices for hydrocephalus
1. All Cause Mortality 2. Disease Progression 3. Death 4. Morbidity
outcomes:
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Cystic Fibrosis Pulmonary Exacerbation 4. Forced expiratory flow rate between 25-75% of vital capacity 5. Cystic Fibrosis Questionnaire-Revised 6. Adverse Event 7. Sputum density
outcomes:
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Serious Adverse Event 4. Cystic Fibrosis Pulmonary Exacerbation 5. Lung function test 6. Withdrawal Due To Adverse Events 7. Adverse Event 8. Time-to-Event
outcomes:
Vitamin K supplementation for cystic fibrosis
1. Osteoclasia 2. Bone Density 3. Bleeding cessation 4. Blood Coagulation Disorder 5. Quality of Life 6. Fracture 7. Adverse Event 8. Protein Induced By Vitamin K Absence Or Antagonist II 9. Time-to-Event
outcomes:
Multi‐nutrient fortification of human milk for preterm infants
1. Body Mass Index 2. Body Composition 3. Psychomotor Development Impaired 4. Growth 5. Hearing impairment 6. Blindness 7. Necrotizing Enterocolitis 8. Head Circumference 9. Cerebral Palsy 10. Weight Gain 11. Height and growth measurements 12. Neurodevelopmental Delay
outcomes:
Effects of total fat intake on body fatness in adults
1. Body Mass Index 2. Waist circumference 3. Body Fat Finding 4. Body weight 5. Blood Pressure 6. Quality of Life 7. Measurement Of Serum Lipid Level
outcomes:
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants
1. Body weight 2. Breast Milk 3. Breastfeeding 4. Adverse Event
outcomes:
Interventions for congenital talipes equinovarus (clubfoot)
1. Assessment Using Assessment Scale 2. Gait 3. Short Form Health Survey - 36 4. Childhood Health Assessment Questionnaire 5. Quality of Life 6. Pirani Score 7. Foot Alignment 8. Adverse Event
outcomes:
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Cystic Fibrosis Pulmonary Exacerbation 4. Quality of Life 5. Length Of Stay 6. Sputum Finding 7. Death 8. Adverse Event 9. Time-to-Event
outcomes:
Artificial corneas versus donor corneas for repeat corneal transplants
1. Visual Acuity Testing 2. Graft Rejection 3. Enucleation Of Eyeball
outcomes:
Alarm interventions for nocturnal enuresis in children
1. Nocturnal Enuresis 2. Adverse Event
outcomes:
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne
1. Treatment Withdrawal 2. Patient's Global Evaluation 3. Clinical Improvement
outcomes:
Corticosteroids as standalone or add‐on treatment for sore throat
1. Disease Recurrence 2. Clinical Resolution 3. Absenteeism 4. Adverse Event 5. Time-to-Event 6. Pain Relief
outcomes:
Inhaled mannitol for cystic fibrosis
1. Forced Vital Capacity 2. Forced Expiratory Volume 3. Peak Expiratory Flow Rate 4. Lung function test 5. Adverse Event 6. Health-Related Quality of Life
outcomes:
Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children
1. Catheter Placement 2. Central Venous Catheter Associated Bloodstream Infection 3. Occlusion Of Catheter 4. Time-to-Event 5. Bacterial Colonization
outcomes:
Oscillating devices for airway clearance in people with cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Cystic Fibrosis Pulmonary Exacerbation 4. Sputum 5. Expiratory Reserve Volume 6. Forced expiratory flow rate between 25-75% of vital capacity 7. Patient Satisfaction
outcomes:
Tonsillectomy versus tonsillotomy for obstructive sleep‐disordered breathing in children
1. Postoperative Hemorrhage 2. Postoperative Complication 3. Postoperative Pain 4. Intraoperative Hemorrhage 5. Primary Post Tonsillectomy Hemorrhage 6. Repeat surgery 7. Quality of Life 8. Breathing-related Sleep Disorder 9. Secondary Post Tonsillectomy Hemorrhage 10. Tonsillar Hypertrophy 11. Able To Perform All Activities Of Daily Living
outcomes:
Treating progressive disseminated histoplasmosis in people living with HIV
1. Death 2. Treatment discontinued 3. Nephrotoxicity
outcomes:
Clonazepam add‐on therapy for drug‐resistant epilepsy
1. Seizure 2. Adverse Event
outcomes:
Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in children
1. All Cause Mortality 2. Growth pattern 3. Rickets 4. Adverse Event 5. Morbidity 6. Health-Related Quality of Life
outcomes:
Non‐invasive respiratory support for the management of transient tachypnea of the newborn
1. Transitory Tachypnea Of Newborn 2. Duration of Symptom 3. Pneumothorax 4. All Cause Mortality 5. Duration Of Hospital Stay 6. Mechanical ventilation
outcomes:
Interventions for fatigue in inflammatory bowel disease
1. Serious Adverse Event 2. Quality of Life 3. Fatigue 4. Withdrawal Due To Adverse Events 5. Adverse Event
outcomes:
Anthelmintic drugs for treating ascariasis
1. Faecal egg count 2. Parasitic infection 3. Adverse Event
outcomes:
Omega‐3 fatty acid supplementation for cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Growth 4. Cystic Fibrosis Pulmonary Exacerbation 5. Essential Fatty Acid Deficiency 6. Diarrhoea 7. Hospitalization 8. Withdrawal Due To Adverse Events 9. Lung function test 10. Adverse Event 11. Nutritional Finding 12. Antibiotic Therapy
outcomes:
Rinse‐free hand wash for reducing absenteeism among preschool and school children
1. Gastrointestinal disorder 2. Acute Respiratory Infections 3. Skin Reaction 4. Illness 5. Absenteeism 6. Absenteeism Or Truancy
outcomes:
Agricultural and nutritional education interventions for reducing aflatoxin exposure to improve infant and child growth in low‐ and middle‐income countries
1. Birth Length 2. Birth Weight 3. Low Birth Weight Infant
outcomes:
EEG for children with complex febrile seizures
1. Seizure 2. Adverse Event
outcomes:
Clonidine for pain in non‐ventilated infants
1. Pain 2. Pain Scale 3. Procedural Pain
outcomes:
Early versus late parenteral nutrition for critically ill term and late preterm infants
1. All Cause Mortality 2. Healthcare associated infectious disease 3. Death 4. Duration Of Hospital Stay 5. Hypoglycemia 6. Infection Of Bloodstream 7. Mechanical ventilation 8. Time-to-Event
outcomes:
Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections
1. Acute Respiratory Infections
outcomes:
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation
1. Forced Expiratory Volume 1 2. Serious Adverse Event 3. Lung function test 4. Adverse Event 5. Survival
outcomes:
Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP)
1. Death
outcomes:
Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants
1. Chronic Lung Disease 2. All Cause Mortality 3. NEC Bell Stage II 4. Necrotizing Enterocolitis 5. Sepsis 6. Duration Of Hospital Stay 7. Fungal Infection
outcomes:
Interventions for preventing and managing advanced liver disease in cystic fibrosis
1. Haemorrhage 2. Adverse Event
outcomes:
Physical therapies for postural abnormalities in people with cystic fibrosis
1. Pain 2. Rotational Deformity Of Trunk 3. Quality of Life
outcomes:
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia
1. Severe Adrenal Insufficiency 2. General Finding Of Height 3. Subfertility 4. Preventative intervention 5. Adrenal Neoplasms 6. Quality of Life 7. Androgen Measurement 8. Osteopenia
outcomes:
Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
1. Pneumothorax 2. Intraventricular Hemorrhage 3. Bronchopulmonary Dysplasia Of Newborn 4. Death 5. Mechanical ventilation
outcomes:
Diaphragm‐triggered non‐invasive respiratory support in preterm infants
1. Treatment Failure 2. Bronchopulmonary Dysplasia Of Newborn 3. Death 4. Respiratory Failure
outcomes:
Postnatal corticosteroids for transient tachypnoea of the newborn
1. Persistent Pulmonary Hypertension Of The Newborn 2. Transitory Tachypnea Of Newborn 3. Duration of Symptom 4. Hyperglycemia 5. Continuous Positive Airway Pressure Ventilation 6. Duration Of Hospital Stay 7. Hospitalization 8. Mechanical ventilation 9. Gastrointestinal Bleeding
outcomes:
Immunosuppressive agents for treating IgA nephropathy
1. Infection 2. Urine Protein Test 3. End Stage Kidney Disease 4. Glomerular Filtration Rate 5. IgA Nephropathy 6. Serum Creatinine 7. Kidney Replacement 8. Death 9. Raised Serum Creatinine 10. Cancer 11. Clinical Improvement 12. Renal Dialysis
outcomes:
Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
1. All Cause Mortality 2. Upper Gastrointestinal Hemorrhage 3. Serious Adverse Event 4. Health-Related Quality of Life
outcomes:
Probiotics for maintenance of remission in ulcerative colitis
1. Therapeutic Procedure 2. Relapse 3. Ulcerative Colitis In Remission 4. Serious Adverse Event 5. Withdrawal Due To Adverse Events 6. Health-Related Quality of Life
outcomes:
Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age
1. Anemia 2. Blood Iron Status 3. Body Measurements 4. Iron Deficiency
outcomes:
Timing of hypertonic saline inhalation for cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Cystic Fibrosis 4. Lung Finding 5. Quality of Life 6. Sputum Finding 7. Lung function test 8. Adverse Event 9. Patient-Reported Outcome
outcomes:
Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization
1. Arterial Thrombosis 2. Minor Bleed 3. Venous Thrombosis 4. Major Bleed
outcomes:
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants
1. Treatment Failure 2. Serum Creatinine 3. Necrotizing Enterocolitis 4. Repair Of Patent Ductus Arteriosus 5. Oliguria 6. Mechanical ventilation 7. Patent Ductus Arteriosus
outcomes:
Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants
1. Red Blood Cell Transfusion
outcomes:
Surfactant for pulmonary haemorrhage in neonates
1. Pulmonary Hemorrhage 2. All Cause Mortality 3. Death
outcomes:
Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants
1. Sepsis
outcomes:
Paracetamol (acetaminophen) for prevention or treatment of pain in newborns
1. Heart Rate 2. Respiratory Rate 3. Pain 4. Pain Scale 5. General Eye Examination 6. Crying 7. Grimaces 8. Oxygen Saturation 9. Partial Arterial Pressure Of Oxygen 10. Measurement Of Arterial Partial Pressure Of Carbon Dioxide
outcomes:
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
1. Serious Adverse Event 2. Treatment Failure 3. Withdrawal Due To Adverse Events 4. Adverse Event
outcomes:
Interventions for chronic pruritus of unknown origin
1. Parent-Reported Outcome 2. Patient-Reported Outcome
outcomes:
Probiotics for people with cystic fibrosis
1. Cystic Fibrosis Pulmonary Exacerbation 2. Body weight 3. C-reactive Protein level 4. Hospitalization 5. Lung function test 6. Adverse Event 7. Health-Related Quality of Life 8. Forced Expiratory Volume 1 9. All Cause Mortality 10. Serious Adverse Event 11. Blood Cytokine Test 12. Deficiency Of Pyruvate Kinase 13. Sputum Finding 14. C-reactive Protein Increased 15. Faecal Calprotectin
outcomes:
Improving vaccination uptake among adolescents
1. Hepatitis B Vaccine 2. Costs and Cost Analysis 3. Vaccination 4. Vaccine-preventable disease 5. Vaccine 6. Adverse Event
outcomes:
Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury
1. Pulmonary Edema 2. Acute Renal Failure 3. Finding Of Intracranial Pressure 4. Death 5. Glasgow Outcome Scale
outcomes:
Anti‐inflammatory medications for obstructive sleep apnoea in children
1. Serious Adverse Event 2. Oxygen Desaturation Index 3. Respiratory arousal index 4. Capillary Oxygen Concentration Measurement 5. Apnoea Hypopnoea Index
outcomes:
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
1. All Cause Mortality 2. Upper Gastrointestinal Hemorrhage 3. Serious Adverse Event 4. Health-Related Quality of Life
outcomes:
Topical antiseptics for chronic suppurative otitis media
1. Hearing 2. Otalgia 3. Quality of Life 4. Earache 5. Chronic Suppurative Otitis Media 6. Otorrhea 7. Ototoxicity
outcomes:
Drug treatment for spinal muscular atrophy types II and III
1. Disability 2. Assessment Of Quality Of Life 3. Paediatric Quality of Life Inventory 4. Forced Expired Volume in one second/Forced Vital Capacity Ratio 5. Death 6. Gross Motor Function Measure 7. Ability to walk 8. Motor function 9. Lung function test 10. Muscle Strength 11. Adverse Event 12. Mechanical ventilation
outcomes:
Antibiotics versus topical antiseptics for chronic suppurative otitis media
1. Hearing 2. Otalgia 3. Quality of Life 4. Earache 5. Chronic Suppurative Otitis Media 6. Otorrhea 7. Ototoxicity
outcomes:
Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors
1. Dietary Fat Intake 2. Dietary Intake Finding 3. Fruit 4. Physical Activity Level 5. Energy Intake 6. Adverse Event 7. Protein Food 8. Sugar - Food 9. Dietary Sodium Intake 10. Carbohydrate Food 11. Drinks 12. Vegetable 13. Moderate-to-vigorous intensity physical activity
outcomes:
Topical antibiotics for chronic suppurative otitis media
1. Hearing 2. Otalgia 3. Quality of Life 4. Earache 5. Chronic Suppurative Otitis Media 6. Otorrhea 7. Ototoxicity
outcomes:
Decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury
1. Death 2. Glasgow Outcome Scale 3. Adverse Event
outcomes:
Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA)
1. Activities of Daily Living 2. Postoperative Pain 3. Corticosteroids - Otological 4. Surgery 5. Pfapa Syndrome 6. Quality of Life 7. Absences 8. Complication 9. Hemorrhage 10. Fever
outcomes:
Racecadotril for acute diarrhoea in children
1. Oral Rehydration Therapy 2. Diarrhoea 3. Stool Finding
outcomes:
Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis
1. Paralytic Poliomyelitis 2. Antibody Titer 3. Seroconversion 4. Adverse Event
outcomes:
Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis
1. Forced Expiratory Volume 1 2. Serious Adverse Event 3. Cystic Fibrosis Pulmonary Exacerbation 4. Quality of Life 5. Chronic Infectious Disease 6. Time-to-Event 7. Infection due to Pseudomonas Aeruginosa 8. Bacterial Colonization
outcomes:
Prophylactic antibiotics for penetrating abdominal trauma: duration of use and antibiotic choice
1. Surgical Site Infection 2. Abdominal Infection 3. Death
outcomes:
Interventions for managing halitosis
1. Breath odour
outcomes:
Drug treatment for spinal muscular atrophy type I
1. Finding Related To Ability To Stand 2. Finding Of Infant Milestone 3. Finding Related To Ability To Roll 4. Assisted Breathing 5. Death 6. Finding Related To Ability To Sit Up 7. Adverse Event
outcomes:
Iron therapy for preoperative anaemia
1. Blood Transfusion 2. Postoperative Morbidity 3. Quality of Life 4. Death 5. Hemoglobin concentration
outcomes:
Primary closure versus delayed or no closure for traumatic wounds due to mammalian bite
1. Surgical Scar Finding 2. Wound Healing 3. Time-to-Event 4. Wound Infection
outcomes:
Corticosteroids for treating sepsis in children and adults
1. Single organ failure 2. All Cause Mortality 3. Hyperglycemia 4. Length Of Stay 5. Death 6. Septic Shock 7. Intensive Care 8. Superimposed Infection 9. Therapeutic Response
outcomes:
Beginning reading interventions for children and adolescents with intellectual disability
1. Reading 2. Stigma 3. Problem Behavior 4. Test of Word Reading Efficency-Sight Word Efficency 5. Test of Word Reading Efficiency-Phonemic Decoding Efficiency
outcomes:
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis
1. Paralytic Poliomyelitis 2. Vaccine associated paralytic poliomyelitis 3. Humoral immune response 4. Acute Paralytic Poliomyelitis, Wild Virus, Imported 5. Neutralizing antibody
outcomes:
Parent training programmes for managing infantile colic
1. Duration of Symptom 2. Excessive Crying 3. Choking 4. Crying Infant 5. Apparent Life-threatening Event In Infant
outcomes:
Intravenous immunoglobulins for epilepsy
1. Seizure 2. Patient Satisfaction
outcomes:
Video feedback for parental sensitivity and attachment security in children under five years
1. Parental stress 2. Problematic Behavior In Children 3. Anxious Parent 4. Attachment Security 5. CARE Index 6. Parental Sensitivity 7. Parenting
outcomes:
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis
1. Forced Expiratory Volume 1 2. Exercise Tolerance Test 3. Mucus Discharge 4. General well-being 5. Cystic Fibrosis Pulmonary Exacerbation 6. Respiratory Function 7. Adverse Event
outcomes:
Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment
1. Dental Caries
outcomes:
Human milk‐derived fortifier versus bovine milk‐derived fortifier for prevention of mortality and morbidity in preterm neonates
1. Body weight 2. Infant Feeding Problem 3. Late Onset Neonatal Sepsis 4. Head Circumference 5. Necrotizing Enterocolitis 6. Death 7. Height and growth measurements
outcomes:
Intranasal corticosteroids for non‐allergic rhinitis
1. Quality Of Life Scale 2. Epistaxis 3. Quality of Life 4. Visual Analog Scale 5. Peak Expiratory Flow Rate 6. Non-allergic Rhinitis
outcomes:
Interventions to reduce Staphylococcus aureus in the management of eczema
1. Clinician-Reported Outcome 2. Patient Global Impression of Improvement 3. Patient-Reported Outcome
outcomes:
Stopping enteral feeds for prevention of transfusion‐associated necrotising enterocolitis in preterm infants
1. Growth 2. Feeding intolerance 3. Necrotizing Enterocolitis 4. Death 5. Duration Of Hospital Stay 6. Infant Feeding Method
outcomes:
Medical and surgical interventions for the treatment of urinary stones in children
1. Serious Adverse Event 2. Urolithiasis 3. Repeat surgery 4. Complication 5. Duration Of Hospital Stay 6. Therapeutic Response
outcomes:
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy
1. Pain 2. Finding Of Gait 3. Observer-Reported Outcome 4. Spasticity 5. Muscle Weakness 6. Passive Range Of Hip Abduction 7. Gross Motor Function Measure 8. Motor function 9. Upper Respiratory Tract Finding 10. Finding Of Measures Of Gait 11. Passive ankle dorsiflexion
outcomes:
Valproate for acute mania
1. Withdrawn From Research Study 2. Mania 3. Sedation 4. Adverse Event 5. Therapeutic Response
outcomes:
Antioxidant supplementation for lung disease in cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Forced Expiratory Volume 4. Cystic Fibrosis Pulmonary Exacerbation 5. Quality of Life 6. Adverse Event 7. Nutritional status
outcomes:
Inhaled steroids with and without regular formoterol for asthma: serious adverse events
1. All Cause Mortality 2. Serious Adverse Event 3. Asthma-Related Death 4. Asthma
outcomes:
Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth infection
1. Soil-transmitted helminth infection 2. Diarrhoea
outcomes:
Conservative interventions for treating functional daytime urinary incontinence in children
1. Urinary Incontinence Care 2. Functional Urinary Incontinence 3. Treatment Success 4. Pad Test For Incontinence 5. Number of Pads Used 6. Urinary Frequency Volume Chart 7. Patient-Reported Outcome
outcomes:
Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy
1. Cesarean Section 2. Birth Weight 3. Morbidity Index 4. Apgar Score 5. Stillbirth 6. Perinatal Death 7. Neonatal Death 8. Pre-eclampsia 9. Pregnancy Loss 10. Intensive Care 11. Maternal Death
outcomes:
Public health deworming programmes for soil‐transmitted helminths in children living in endemic areas
1. Cognitive function 2. General well-being 3. Assessment Of Performance At School 4. Body weight 5. Death 6. Height and growth measurements 7. School Attendance 8. Hemoglobin concentration
outcomes:
Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Hospital admission 4. Lung function test
outcomes:
Respiratory muscle training in children and adults with neuromuscular disease
1. Forced Vital Capacity 2. Maximum inspiratory pressure 3. Short Form Health Survey - 36 4. Performance Test Of Activities Of Daily Living 5. Respiratory Muscle Strength 6. Nasal peak inspiratory air flow 7. Total Lung Capacity 8. Hospitalization 9. Activities Of Daily Living Assessment
outcomes:
Homeopathy for treatment of irritable bowel syndrome
1. Quality of Life 2. Abdominal Pain 3. Stool Finding 4. Global Assessment 5. Adverse Event 6. Clinical Improvement
outcomes:
Altering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumption
1. Tobacco Smoking Consumption 2. Alcoholic Drink 3. Food
outcomes:
Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis
1. Body Mass Index 2. Forced Vital Capacity 3. Forced Expiratory Volume 4. Cystic Fibrosis Pulmonary Exacerbation 5. Antibiotic resistance test 6. Intravenous Antibiotic Therapy 7. Lung function test 8. Nephrotoxicity 9. Time-to-Event 10. Ototoxicity
outcomes:
Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health
1. Maternal Diabetes Mellitus With Hypoglycemia Affecting Fetus Or Newborn 2. Shoulder Dystocia 3. Cesarean Section 4. Fetal Death 5. Type 2 Diabetes Mellitus 6. Large For Gestational Age 7. Neonatal Hypoglycemia 8. Nerve Palsy 9. Neonatal Death 10. Perinatal Death 11. Fracture 12. Hypertension Associated Disorders Of Pregnancy
outcomes:
Chlorhexidine bathing of the critically ill for the prevention of hospital‐acquired infection
1. Infection 2. Skin Reaction 3. Length Of Stay 4. Death
outcomes:
Contact tracing strategies in household and congregate environments to identify cases of tuberculosis in low‐ and moderate‐incidence populations
1. Tuberculosis
outcomes:
Sulthiame add‐on therapy for epilepsy
1. Seizure
outcomes:
TNF‐α blockers for the treatment of Kawasaki disease in children
1. Coronary Arteriography Abnormal
outcomes:
Prebiotics for the prevention of hyperbilirubinaemia in neonates
1. Bilirubin Unconjugated 2. Hyperbilirubinemia 3. Kernicterus Of Newborn 4. Exchange Transfusion 5. Death 6. Duration Of Hospital Stay 7. Stool Finding 8. Phototherapy Of Newborn 9. Adverse Event 10. Neurodevelopmental Delay
outcomes:
eHealth interventions for people with chronic kidney disease
1. Self Efficacy 2. Dietary Intake Finding 3. Costs and Cost Analysis 4. Traffic Vehicular Accidental Death 5. Physical activity 6. Renal Function Monitoring 7. Single Appointment 8. Medication adherence 9. Hospitalization 10. Patient compliance 11. Patient Satisfaction 12. Electrolyte Regulation 13. Excess Interdialytic Weight Gain 14. Morbidity Index 15. Dietary Sodium Intake 16. Quality of Life 17. Self-management 18. Death 19. Vehicle Accident 20. Anxiety 21. Nutritional status
outcomes:
Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease
1. Crohn's Disease 2. Relapse 3. Serious Adverse Event 4. Withdrawal Due To Adverse Events 5. Adverse Event
outcomes:
Protein hydrolysate versus standard formula for preterm infants
1. Necrotizing Enterocolitis 2. Enteral Feeding Intolerance
outcomes:
Interventions for preventing obesity in children
1. Body Composition 2. Body Mass Index 3. Obesity 4. Body weight 5. Height 6. Ponderal Index 7. Overweight
outcomes:
Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children
1. All Cause Mortality 2. Acute Renal Failure 3. Electrolyte disorder 4. Serum Chloride 5. Organ dysfunction 6. Plasma potassium 7. Plasma pH
outcomes:
Community first responders for out‐of‐hospital cardiac arrest in adults and children
1. Cardiopulmonary Resuscitation 2. Neurological Functional Rehabilitation
outcomes:
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
1. Adverse Drug Reaction 2. Treatment Failure 3. Seizure 4. Non-compliant Behavior
outcomes:
Genetic testing for prevention of severe drug‐induced skin rash
1. Hypersensitivity Reaction 2. Death 3. Sequela 4. Hospitalization 5. Skin Rash
outcomes:
Interventions for morphea
1. Physician's Global Evaluation 2. Patient's Global Evaluation 3. Clinical Improvement
outcomes:
Singing as an adjunct therapy for children and adults with cystic fibrosis
1. Quality of Life 2. Peak Flow Rate 3. Respiratory Function
outcomes:
Inositol in preterm infants at risk for or having respiratory distress syndrome
1. Infant Death 2. All Cause Mortality 3. Retinopathy Of Prematurity 4. Intraventricular Hemorrhage 5. Bronchopulmonary Dysplasia Of Newborn 6. Necrotizing Enterocolitis 7. Sepsis 8. Death
outcomes:
Interventions for treating neuropathic pain in people with sickle cell disease
1. Time to clinical improvement 2. Quality Of Sleep 3. Quality of Life 4. Adverse Event 5. Pain Relief 6. Patient's Global Evaluation 7. Patient-Reported Outcome
outcomes:
Inhaled corticosteroids for cystic fibrosis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Improved Exercise Tolerance 4. Cystic Fibrosis Pulmonary Exacerbation 5. Quality of Life 6. Intravenous Antibiotic Therapy 7. Lung function test 8. Adverse Event 9. Asthma
outcomes:
Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants
1. All Cause Mortality 2. Anemia 3. Upper Gastrointestinal Haemorrhage
outcomes:
Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia
1. Medication adherence
outcomes:
Banked preterm versus banked term human milk to promote growth and development in very low birth weight infants
1. Growth 2. Head Circumference 3. Weight Gain 4. Height and growth measurements 5. Neurodevelopmental Delay
outcomes:
Surgery for epilepsy
1. Seizure
outcomes:
Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B
1. All Cause Mortality 2. Serious Adverse Event 3. Health-Related Quality of Life
outcomes:
Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years
1. Impulsive Behavior 2. Inattention 3. Hyperactivity 4. Behavior 5. Finding Related To Ability To Interact With Others 6. Conners' Parent Rating Scale 7. Emotional regulation
outcomes:
Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease
1. Relapse 2. Serious Adverse Event 3. Disease Recurrence 4. Withdrawal Due To Adverse Events 5. Adverse Event 6. Health-Related Quality of Life
outcomes:
Probiotics for preventing acute otitis media in children
1. Antibacterials For Systemic Use 2. Absences 3. Acute Otitis Media 4. Adverse Event
outcomes:
Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. 6-minute Walk Test 4. Antibody Titer 5. Infusion related reaction 6. Polysulfated Glycosaminoglycan 7. Quality of Life 8. Death 9. Respiratory Function
outcomes:
Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth
1. Body weight 2. Growth Rate 3. Body Height
outcomes:
Lipid emulsions for parenterally fed preterm infants
1. Parenteral Nutrition Associated Liver Disease 2. Neonatal cholestasis 3. Growth 4. Neurodevelopmental Delay 5. Conjugated Bilirubin Level Raised 6. Retinopathy Of Prematurity 7. Bronchopulmonary Dysplasia Of Newborn 8. Growth Rate 9. Head Circumference 10. Death 11. Sepsis 12. Clinical Resolution 13. Weight Gain
outcomes:
Lipid emulsions for parenterally fed term and late preterm infants
1. Parenteral Nutrition Associated Liver Disease 2. Alkaline Phosphatase level 3. Conjugated Bilirubin Level Raised 4. Hypertriglyceridemia 5. Growth 6. Growth Rate 7. Sepsis 8. Death 9. Clinical Resolution 10. Weight Gain 11. Neurodevelopmental Delay 12. Cholestasis
outcomes:
Lithium for acute mania
1. Withdrawn From Research Study 2. Tremor 3. Manic Bipolar I Disorder In Remission 4. Sedated 5. Nausea 6. Weight Gain 7. Adverse Event 8. Sleepiness 9. Therapeutic Response
outcomes:
Interventions for promoting participation in shared decision‐making for children and adolescents with cystic fibrosis
1. Shared Decision Making 2. Quality of Life 3. Adverse Event
outcomes:
Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age
1. Death 2. Weight Gain 3. Clinical deterioration 4. Clinical Improvement
outcomes:
Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates
1. All Cause Mortality
outcomes:
Preventive lipid‐based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes
1. Anemia 2. Underweight 3. Nutritional Wasting 4. Child Development 5. Nutritional Stunting
outcomes:
Family therapy approaches for anorexia nervosa
1. All Cause Mortality 2. Anorexia Nervosa In Remission
outcomes:
Probiotics for the prevention of pediatric antibiotic‐associated diarrhea
1. Adverse Event 2. Microbiology test 3. Antibiotic-associated Diarrhea
outcomes:
MVA85A vaccine to enhance BCG for preventing tuberculosis
1. Serious Adverse Event 2. Tuberculosis 3. Skin Reaction 4. Adverse Event
outcomes:
Haloperidol discontinuation for people with schizophrenia
1. Relapse 2. Patient Satisfaction Score 3. Global Assessment
outcomes:
Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis
1. Treatment Success 2. Time-to-Event
outcomes:
Medical treatment for botulism
1. Feeding Finding 2. Death 3. Hospitalization 4. Death In Hospital 5. Adverse Event 6. Mechanical ventilation
outcomes:
First aid glucose administration routes for symptomatic hypoglycaemia
1. Finding Of Glucose Concentration, Dipstick 2. Blood glucose measurement 3. Adverse Event 4. Finding Of Blood Concentration, Dipstick
outcomes:
Home use of interdental cleaning devices, in addition to toothbrushing, for preventing and controlling periodontal diseases and dental caries
1. Periodontitis 2. Adverse Event 3. Gingivitis 4. Interproximal Enamel Caries 5. Dental Plaque
outcomes:
Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents
1. Disability 2. Headache 3. Depression 4. Anxiety 5. Patient Global Impression of Improvement 6. Adverse Event
outcomes:
Long‐term antibiotics for preventing recurrent urinary tract infection in children
1. Recurrent Urinary Tract Infection 2. Antimicrobial resistance 3. Adverse Event 4. Urine Culture Positive
outcomes:
Constraint‐induced movement therapy in children with unilateral cerebral palsy
1. Hands 2. Melbourne Assessment Of Unilateral Upper Limb Function 3. Dexterity 4. ABILHAND-Kids Questionnaire 5. Self-care practice 6. Canadian Occupational Performance Measure 7. Quality Of Upper Extremity Skills Test Scale
outcomes:
Supplemental perioperative intravenous crystalloids for postoperative nausea and vomiting
1. Serious Adverse Event 2. Hospitalization 3. Postoperative Vomiting 4. Postoperative Nausea 5. Antiemetics And Antinauseants
outcomes:
Family‐based prevention programmes for alcohol use in young people
1. Drinking Binge 2. Alcohol Use 3. Alcohol Intoxication
outcomes:
Multiple‐micronutrient supplementation for women during pregnancy
1. Small For Gestational Age 2. Premature Delivery 3. Stillbirth 4. Neonatal Death 5. Perinatal Death 6. Low Birth Weight Infant
outcomes:
Probiotics to prevent infantile colic
1. Duration of Symptom 2. Infantile Colic 3. Wessell Criteria 4. Mental state 5. Depression 6. Crying
outcomes:
Dental cavity liners for Class I and Class II resin‐based composite restorations
1. Tooth Restoration Failure 2. Tooth Sensitivity To Pressure
outcomes:
Fluoride toothpastes of different concentrations for preventing dental caries
1. Dental Caries 2. Non Carious Cervical Lesion 3. Radiographic Radiolucency Of Tooth
outcomes:
Physical exercise training for type 3 spinal muscular atrophy
1. Assessment Using Assessment Scale 2. Paediatric Quality of Life Inventory 3. Functional Assessment 4. Physical Activity Level 5. Manual Testing Of Muscle Function 6. Fatigue 7. Motor Function Measure 8. SF-36 Physical Function Score 9. Serious Adverse Event 10. 6-minute Walk Test 11. Expanded Hammersmith Functional Motor Scale 12. Short Form Health Survey - 36 13. Timed Up And Go Mobility Test 14. Cardiopulmonary Exercise Test 15. Timed 10 Meter Walk 16. Manual Muscle-testing With Total Evaluation Of Body 17. Exercise Capacity 18. Withdrawal Due To Adverse Events 19. Muscle Strength 20. Fatigue Severity Scale
outcomes:
The use of ultrasound guidance for perioperative neuraxial and peripheral nerve blocks in children
1. Transient Neurological Symptoms 2. Pain Scale 3. Neurological Impairment 4. Nerve Block 5. Poisoning By Local Anesthetic 6. Duration of Block 7. Infection 8. Pain 9. Serious Adverse Event 10. Treatment Success 11. Treatment Failure 12. Cardiac Arrest 13. Complication 14. Seizure
outcomes:
Positive end‐expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia
1. Bronchopulmonary Dysplasia Of Newborn 2. Death 3. Mechanical ventilation 4. Neurodevelopmental Delay
outcomes:
Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants
1. Death 2. Neonatal Death 3. Neurodevelopmental Delay
outcomes:
Parenteral versus oral iron therapy for adults and children with chronic kidney disease
1. Ferritin level 2. Allergic Reaction 3. Transfusion 4. Erythropoietin 5. Transferrin Saturation 6. Cardiovascular Mortality 7. Low Blood Pressure 8. Haematocrit finding 9. Estimated glomerular filtration rate 10. Hemoglobin concentration 11. Infection 12. Gastrointestinal Symptom 13. All Cause Mortality 14. Quality of Life 15. Renal Dialysis
outcomes:
Education of family members to support weaning to solids and nutrition in infants born preterm
1. Growth 2. Head Circumference 3. Height and growth measurements 4. Weight Gain 5. Neurodevelopmental Delay
outcomes:
Interventions for primary vesicoureteric reflux
1. Tc99m-dmsa Renal Study 2. Extrinsic Ureteral Obstruction 3. Febrile Urinary Tract Infection 4. Renal Hypertension 5. Urinary Tract Infection 6. Flank Pain 7. Complication Of Injection 8. Adverse Event 9. Urine Culture Positive 10. End Stage Kidney Disease 11. Kidney Finding 12. Treatment Success 13. Clinical Resolution 14. Antimicrobial resistance 15. Intravenous Pyelogram Abnormal 16. Kidney injury
outcomes:
Antibiotic treatment for newborns with congenital syphilis
1. Serious Adverse Event 2. Neonatal Death 3. Adverse Event
outcomes:
Dietary interventions for induction and maintenance of remission in inflammatory bowel disease
1. Relapse 2. Crohn's Disease In Remission 3. Ulcerative Colitis In Remission 4. Adverse Event 5. Health-Related Quality of Life
outcomes:
Needle aspiration versus intercostal tube drainage for pneumothorax in the newborn
1. Drainage Tube In Situ 2. Haemothorax 3. Treatment Success 4. Death 5. Haemorrhage
outcomes:
Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
1. Ferritin level 2. Anemia 3. Iron Deficiency 4. Hemoglobin concentration 5. Iron Deficiency Anemia
outcomes:
Phosphodiesterase 5 inhibitors for pulmonary hypertension
1. Pulmonary Vascular Resistance 2. Euroqol Five Dimension Questionnaire 3. 6-minute Walk Test 4. Short Form Health Survey - 36 5. Right Atrial Pressure 6. Chronic Heart Failure Questionnaire 7. Quality of Life 8. Death 9. Health Status 10. Pulmonary arterial pressure 11. World Health Organisation Functional Class
outcomes:
Pharmacotherapies for cannabis dependence
1. Cannabis Withdrawal 2. Abstinent From Drug Misuse 3. Adverse Event 4. Patient compliance
outcomes:
School‐based self‐management interventions for asthma in children and adolescents: a mixed methods systematic review
1. Asthma Daytime Symptoms 2. Emergency Care 3. Patient-initiated Visit to General Practitioner 4. Asthma Night-time Symptoms 5. Asthma Finding 6. Activities Of Daily Living Impaired 7. Hospitalization 8. Absenteeism 9. Asthma exacerbation 10. Health-Related Quality of Life 11. Carer-Reported Outcome
outcomes:
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non‐pregnant women
1. Adverse Event
outcomes:
Surgical versus conservative interventions for treating fractures of the middle third of the clavicle
1. Pain 2. Treatment Failure 3. Cosmetics 4. Functional ability
outcomes:
Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema
1. Therapeutic Response
outcomes:
Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders
1. Body Mass Index 2. Treatment Withdrawal 3. Eating Disorder Symptoms NEC 4. Body weight 5. Clinical Improvement 6. Binge Eating
outcomes:
Adverse events in people taking macrolide antibiotics versus placebo for any indication
1. Gastrointestinal disorder 2. Taste Disturbance 3. Vomiting 4. Hearing impairment 5. Hepatobiliary Disorders 6. Heart disease 7. Death 8. Bacterial Resistance 9. Nausea 10. Abdominal Pain 11. Diarrhoea 12. Adverse Event
outcomes:
Adrenaline and vasopressin for cardiac arrest
1. All Cause Mortality 2. Signs Of Return Of Spontaneous Circulation 3. Cardiac Rhythm And/or Rate Finding 4. Neurological Finding 5. Survival 6. Emergency Hospital Admission
outcomes:
Postoperative epidural analgesia versus systemic analgesia for thoraco‐lumbar spine surgery in children
1. Solid Food 2. Functional Finding Of Gastrointestinal Tract 3. Length Of Stay 4. Therapeutic mobilization 5. Epidural Abscess 6. Time-to-Event 7. Patient Satisfaction 8. Bowel Action 9. Liquid 10. Pain 11. Vomiting 12. Neurological Finding 13. Complication 14. Passing Flatus 15. Wound Infection
outcomes:
Antiamoebic drugs for treating amoebic colitis
1. Relapse 2. Serious Adverse Event
outcomes:
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis
1. Forced Expiratory Volume 1 2. Cystic Fibrosis Pulmonary Exacerbation 3. Quality of Life 4. Death 5. Adverse Event 6. Time-to-Event 7. Survival
outcomes:
Transfusion of red blood cells stored for shorter versus longer duration for all conditions
1. All Cause Mortality 2. Death In Hospital
outcomes:
Interventions for treating wrist fractures in children
1. Serious Adverse Event 2. Surgery 3. Wrist Joint Deformity 4. General Physical Finding
outcomes:
First aid interventions by laypeople for acute oral poisoning
1. Death
outcomes:
Sedation of children undergoing dental treatment
1. Behavioral
outcomes:
Short‐acting insulin analogues versus regular human insulin for adult, non‐pregnant persons with type 2 diabetes mellitus
1. All Cause Mortality 2. Macrovascular complications 3. Costs and Cost Analysis 4. HbA1c level 5. Hypoglycemic episode 6. Microvascular complications 7. Adverse Event 8. Health-Related Quality of Life
outcomes:
Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants
1. Premature Delivery 2. Surgery 3. Late Onset Neonatal Sepsis 4. Stillbirth 5. Necrotizing Enterocolitis 6. Death 7. Neonatal Death 8. Miscarriage 9. Preterm Infant 10. Sepsis Of The Newborn 11. Infant Feeding Method 12. Gestational Age
outcomes:
Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock
1. Sepsis-associated Organ Dysfunction 2. All Cause Mortality 3. Allergic Reaction 4. Hepatomegaly 5. Sequelae Of Neurological Disorders 6. Mechanical ventilation
outcomes:
Dressings and topical agents for preventing pressure ulcers
1. Pressure ulcer 2. Adverse Event
outcomes:
Oral and intrauterine progestogens for atypical endometrial hyperplasia
1. Vaginal Bleeding 2. Nausea 3. Endometrium Normal
outcomes:
Inhaled steroids with and without regular salmeterol for asthma: serious adverse events
1. All Cause Mortality 2. Serious Adverse Event 3. Asthma-Related Death
outcomes:
Laparoscopic versus open surgery for suspected appendicitis
1. Returns To Baseline Activity Status 2. Abdominal abscess 3. Pain Scale 4. Quality of Life 5. Length Of Stay 6. Time-to-Event 7. Pain Intensity 8. Wound Infection
outcomes:
Oral isotretinoin for acne
1. Serious Adverse Event 2. Acne 3. Therapeutic Response
outcomes:
Omega‐3 fatty acid addition during pregnancy
1. Body Mass Index 2. Small For Gestational Age 3. Labour Induction 4. Costs and Cost Analysis 5. Cognitive Developmental Delay 6. Wechsler Intelligence Scale For Children 7. Bayley Scale Of Infant Development 8. Postpartum Depression 9. Large For Gestational Age 10. Length Of Stay 11. Perinatal Death 12. Hospitalization 13. Low Birth Weight Infant 14. Pre-eclampsia 15. Diabetes Mellitus 16. Length of gestation 17. Fetal Growth Restriction 18. Premature Delivery 19. Pregnancy Prolonged - 42 Weeks 20. Serious Adverse Event 21. Behavior 22. Strengths And Difficulties Questionnaire 23. Intensive Care 24. Intelligence
outcomes:
Phonics training for English‐speaking poor readers
1. Reading 2. Reading comprehension 3. British Ability Scales 4. Spelling ability 5. Reading fluency
outcomes:
Protocol‐directed sedation versus non‐protocol‐directed sedation in mechanically ventilated intensive care adults and children
1. Unintended Endotracheal Extubation 2. Death 3. Tracheostomy 4. Duration Of Hospital Stay 5. Hospitalization 6. Endotracheal Reintubation 7. Intensive Care 8. Mechanical ventilation 9. Time-to-Event
outcomes:
Communication interventions for autism spectrum disorder in minimally verbal children
1. Behavioral 2. Speech And Language Finding 3. Quality of Life 4. Anxiety 5. Non-verbal Communication
outcomes:
Caseworker‐assigned discharge plans to prevent hospital readmission for acute exacerbations in children with chronic respiratory illness
1. Emergency Care 2. Hospitalization 3. Readmission 4. Adverse Event
outcomes:
One‐to‐one oral hygiene advice provided in a dental setting for oral health
1. Gingivitis/gingival Disease 2. Dental Caries 3. Dental Plaque 4. Bleeding On Probing Of Gingivae
outcomes:
Biocompatible dialysis fluids for peritoneal dialysis
1. Rash 2. Dialysis fluid 3. Pain During Inflow Of Dialysate 4. Peritoneal Dialysis-associated Peritonitis 5. Adverse Event 6. Survival 7. Peritoneal dialysis solution 8. Urine Output 9. All Cause Mortality 10. Ultrafiltration 11. Peritoneal Dialysis 12. Toxicity Renal 13. Peritoneal dialysis complication 14. Decreased Renal Function 15. Treatment Failure 16. Plasma Creatinine
outcomes:
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
1. Seizure
outcomes:
Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
1. Treatment Failure 2. Seizure
outcomes:
Leukotriene receptor antagonists for eczema
1. Relapse 2. Eczema Area and Severity Index 3. Severity Scoring of Atopic Dermatitis Index 4. Therapeutic Response 5. Six Area, Six Sign Atopic Dermatitis Severity Score 6. Investigator Global Assessment
outcomes:
Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X‐linked dilated cardiomyopathy
1. Assessment Using Assessment Scale 2. Left Ventricular Function 3. Myocardial Finding 4. Adverse Event
outcomes:
Parent‐mediated interventions for promoting communication and language development in young children with Down syndrome
1. Parental stress 2. Social Interaction 3. Language Attrition 4. Speech And Language Development Finding 5. Finding Related To Ability To Use Language 6. Parental Sensitivity 7. Patient compliance
outcomes:
Dietary modifications for infantile colic
1. Duration of Symptom 2. Frequency of symptom 3. Sleep Finding 4. Parent 5. Adverse Reaction 6. Crying Infant 7. Quality of Life 8. Parent satisfaction 9. Dietary Treatment For Disorder
outcomes:
Eszopiclone for insomnia
1. Serious Adverse Event 2. Mental Alertness 3. Sleep Finding 4. Wakefulness 5. Withdrawal Sign Or Symptom 6. Sleep Latency Test 7. Rebound Insomnia
outcomes:
Psychological interventions for needle‐related procedural pain and distress in children and adolescents
1. Pain Management 2. Distress 3. Pain Intensity
outcomes:
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
1. Hellp Syndrome 2. Increased Diastolic Arterial Pressure 3. Premature Delivery 4. Increased Systolic Arterial Pressure 5. Stillbirth 6. Neonatal Death 7. Pre-eclampsia 8. Intensive Care 9. Proteinuria
outcomes:
Psychological therapies for the management of chronic and recurrent pain in children and adolescents
1. Disability 2. Pain 3. Depression 4. Anxiety 5. Pain Relief 6. Pain Intensity
outcomes:
Antibiotics for treating scrub typhus
1. Fever Defervescence 2. Serious Adverse Event 3. Treatment Failure
outcomes:
Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
1. All Cause Mortality 2. HbA1c level 3. Cardiovascular observations 4. Body weight 5. Death 6. Fasting Blood Glucose 7. Hypoglycemia 8. Adverse Event 9. Estimated glomerular filtration rate
outcomes:
Topical and systemic antifungal therapy for chronic rhinosinusitis
1. Epistaxis 2. Headache 3. Allergic Reaction 4. Irritation Symptom 5. Chronic Rhinosinusitis 6. Quality of Life 7. Abnormal Digestive Tract Function 8. Drug toxicity 9. Patient-Reported Outcome
outcomes:
Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants
1. Infection 2. Pneumonia 3. Enteral nutrition 4. Late Onset Neonatal Sepsis 5. Necrotizing Enterocolitis 6. Death 7. Duration Of Hospital Stay 8. Adverse Event
outcomes:
Head‐to‐head trials of antibiotics for bronchiectasis
1. Acute Exacerbation Of Bronchiectasis 2. Serious Adverse Event 3. Treatment Failure 4. Quality of Life 5. Death 6. Purulent Sputum 7. Microbiology test
outcomes:
Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients
1. All Cause Mortality 2. Amputation 3. Evaluation Of Ulcer Healing 4. Wound Healing 5. Perfusion Of Lower Limb 6. Pain Relief
outcomes:
Impact of medication reconciliation for improving transitions of care
1. Discrepancy 2. Hospital admission 3. Adverse Event
outcomes:
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
1. Disease Recurrence 2. Recurrent Disease 3. Healing
outcomes:
Client feedback in psychological therapy for children and adolescents with mental health problems
1. Treatment Withdrawal 2. Mental disorder 3. Psychotherapy 4. Building patient relationship 5. Psychosocial functioning 6. Clinical Improvement